Friday, April 1, 2011

Potential Campaigns: GVRS, EGYH, GNBP

Geneva Resources, Inc. ( OTC:GVRS ) recently filed Articles of Merger with the
Nevada Secretary of State in order to merge with its wholly-owned subsidiary and
change its name to Sono Resources. The name change was effective with the Nevada
Secretary of State of February 10, 2011 when the Articles of Merger were filed.
The company changed its name to Sono Resources as it better reflects the nature
of proposed business operations. Geneva Resources stock is currently trading at
$0.860. The stock is currently trading above its 50-day and 200-day moving
average of $0.615 and $0.570, indicating bullish sentiment. The company stock
has traded in the range of $0.14 and $1.50 during the past 52 weeks. Geneva
Resources engages in the business of exploration of precious metals with a focus
on the exploration and development of gold deposits in North America and
internationally. ENERGY HOLDINGS INTL ( PINK:EGYH ) is currently trading at
$0.550. The company stock has traded in the range of $0.04 and $1.01 during the
past 52 weeks. The company's market cap is $16.37 million. Energy Holdings
International focuses on acquiring, developing, and managing oil and gas
properties in the Middle East, Asia, and the Americas. Genesis Biopharma Inc. (
OTC:GNBP )recently appointed William H. Andrews Ph.D. to its Board of Directors.
 Dr. Andrews has 30 years of experience in biotechnology research and
development, and is currently President and Chief Executive Officer of Sierra
Sciences. Previously, Dr. Andrews was director of technology development for EOS
and also served as director of molecular biology at both Geron Corporation and
Codon Corporation. Genesis Biopharmais currently trading at $1.20. Genesis
Biopharmastock touched the high of $1.21 and lowest price in today's session
is $1.20. The company stock has traded in the range of $0.95 and $1.26 during
the past 52 weeks. The company's market cap is $87.65million. Genesis
Biopharma engages in the development and commercialization of drugs and other
clinical solutions for underserved diseases, including metastatic cancers and
lethal infectious diseases.

No comments:

Post a Comment

LinkWithin

Related Posts Plugin for WordPress, Blogger...